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ABSTRACT
Objectives: The aim of this study was to identify the clinical, radiological, and bacteriological fea-
tures, risk factors, and outcome of neonates with bone and joint infections. Study design: Obser-
vational, retrospective, and analytical study of 77 patients less than 2 months of age, admitted to a 
tertiary neonatal intensive care unit (NICU) with the diagnosis of bone or joint infection, based 
on clinical, radiological, and microbiological criteria. Results: Seventy-seven patients with 99 
acute osteoarthritis foci in a 16 year period were included in the study. Risk factors for infection 
could be identifi ed in 69% of the patients. The hip was the most frequent. Staphylococcus aureus 
was the main isolated microorganism. Twenty-nine infants (38%) had sequelae. Hip involvement, 
culture positive, and Staphylococcus aureus isolation were risk factors associated with sequelae. 
Conclusion: Osteoarticular infection is unusual in the neonate; however it is associated with an 
elevated incidence of sequelae. This mandates for a high degree of suspicion to diagnose this poten-
tially disabling entity.
Keywords: osteoarthritis, neonate, Staphylococcus aureus.
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INTRODUCTION
Acute osteoarthritis (AO) in the neonatal pe-
riod is uncommon. The estimated incidence is 
1 to 3 cases per 1000 admissions in Neonatal 
Intensive Care Units.1 Clinical features, micro-
biology, and outcome differ from that of older 
children. Diagnosis may be diffi cult and de-
layed because of the paucity signs and symp-
toms. Poor outcome is related to its potential to 
cause permanent sequelae.2,3
The aim of this investigation was to identify 
the clinical and radiological features, microbi-
ology, risk factors for sequelae, and outcome of 
neonates with AO infection.
PATIENTS AND METHODS
We included all patients with less than two 
months of age admitted to the Neonatal Inten-
sive Care Unit (NICU) of the Hospital Nacional 
de Pediatría “Prof. Dr. Juan P. Garrahan”, Bue-
nos Aires, Argentina, over a period of 16 years 
(1988 –2004). This unit admits about 700 ne-
onates per year and is a tertiary referral center 
in the country.
The diagnosis of bone or joint infection 
was based on clinical, radiological, and micro-
biological criteria. At least two of the following 
criteria had to be met for inclusion in the study: 
1) clinical symptoms; 2) radiological changes; 
3) positive blood or bone or joint cultures; 4) 
aspiration of pus from bone or joint.
Outcome was evaluated by an orthopedic 
surgeon, an infectologist, and a neonatologist 
on the basis of radiographic and clinical fea-
tures. Sequelae included ambulatory disability, 
limb-length discrepancy, and bone growth ab-
normalities.
Mild sequelae were defi ned as local swell-
ing or pain or limited motility and radio-
graphic changes consisting of lytic lesions 
limited to less than one-third of the bone 
shaft, a periosteal reaction or sclerosis. Severe 
sequelae were defi ned as any symptom at the 
infection site and radiographic changes con-
sisting of lytic lesions extending over one-
third of the bone shaft or lesions within the 
growth plaque. Radiographic classifi cation 
(I-V) proposed by Hunka et al. was used for 
hip infection.4 
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STATISTICAL ANALYSIS 
All data were entered and verifi ed with the use of Epi-Info 
6.0. Statistical Data are summarized as mean or median, 
range for continuous variables, frequency and percentages 
for categorical data. Comparative analyses of categorical 
data were performed by chi-square analysis. P-values < 0.05 
were considered as statistically signifi cant. Statistical analy-
ses were calculated with 95% confi dence intervals.
RESULTS
We included 77 patients with 99 AO foci. The mean 
age was 21 (range: 2-53) days, 42 patients (55%) were 
male. Mean gestational age at birth was 38 (range: 26-
42) weeks. Of all patients, 49 (64%) had nosocomial in-
fections, and at least one risk factor for infection was 
present in 53 (69%) patients: high-risk pregnancy in 19 
(25%), prematurity in 15 (20%), birth weight less than 
1500 g in 5 (7%), asphyxia in 16 (21%), central catheter-
ization in 24 (31%), mechanical ventilation in 11 (14%), 
and previous antibiotics in 35 (45%). Less than 4% of 
patients had a history of surgery, necrotizing enterocoli-
tis or steroid medication (Table 1). 
Fourteen patients (18%) had multiple joint involvement. 
The lower extremities were the most commonly affected 
with 79 foci (80%). The hip was the most frequent focus 
affecting 47 (60%), followed by the knee in 23 (30%). Nine-
teen foci were localized in the upper extremities (20%), 12 of 
them (66%) in the shoulder (Table 2 ).
Table 1. Characteristics of patients
        n:77
Variable n Percentage
Age (median in days) 21 (r 2-53) -
Male  42 55
Risk factor for infection 53 69
High risk pregnancy 19 25
Prematurity 15 20
BW < 1500 g 5 7
Asphyxia 16 21
Central catheter 24 31
Mechanical ventilation 11 14
Previous ATB 35 45
Nosocomial infection 49 64
Time to diagnosis 2 (r 1-15)  
Fever 39 50
Pain  69 90
ESD (median) 52 (r 5-145)  
Positive cultures 66 84
Initial abnormal Rx 29 38
Sequelae 29 38
Mortality 1 1
Table 2. Distribution of affected bone and joint
n: 99 sites in 77 newborn
Bone/joint Number of sites % 
Hip 47 47.5
Knee 23 23.3
Shoulder 12 12.2
Ankle 8 8
Elbow 6 6
Others 3 3
Total 99 100
The median time to diagnosis was two days (range: 
1-15). The most common clinical presentation was pain in 
69 patients (90%), motor disability in 71 (96%), tenderness 
in 58 (75%), and erythema in 35 (45%). Fever and sepsis 
were present in 38 patients (50%). Forty-seven percent of 
the patients presented local signs of infection solely.
The median peripheral white blood cell count was 
15.900/mm3 (r: 4.500 - 37.000) with 70% polymorhonuclear 
leukocytes. Erythrocyte sedimentation rates (ESR) were ab-
normal at initial evaluation in 72 patients (93%). Cultures 
were positive in 66 (84%): joint cultures in 53 (82%), and 
blood cultures in 35 (54%). The predominant causative 
organism was Staphylococcus aureus 37 patients (57%), 19 
were methicillin susceptible (Table 3). 
Table 3. Microbiology of bone and joint infection
n: 66 isolation 
Organisms Number of cases %
Staphylococcus aureus 37 56
Gram-negative enteric bacilli: 16 24.3
Klebsiella pneumoniae 8 -
Pseudomona aeruginosa 3 -
Serratia marscecens 1 -
Proteus mirabilis 1 -
Acinetobacter baumanii 1 -
Enterobacter cloacae 1 -
Escherichia coli 1 -
Streptococcus agalactiae 10 15.2
Staphylococcus epidermidis 2 3
Haemophilus influenzae type b 1 1.5
Total 66 100
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Forty-nine patients acquired infection at the hospital, 39 
(80%) of them with microbiological isolation. Community 
infection were acquired in 28 patients, 27 (96%) of them 
with positive culture. Relationship between risk factors and 
etiology is showed in (Table 4). 
All patients were treated with antibiotics for a median 
duration of 40 days. Surgical drainage was performed in 58 
patients (75%).One patient (1%) died because of sepsis. 
Twenty-nine infants (38%) had sequelae. Out of the 29 
sequelae, eleven (38%) were mild and 18 (62%) severe, con-
sidering initial defi nitions. 
By univariate analysis, the risk factors for sequelae were: 
hip involvement (RR = 3.15; 95% CI: 1.55-6.42; p <0.0005), 
positive culture (RR = 5.25; 95% CI: 0.79-35; p <0.02), and 
Staphylococcus aureus isolation (RR = 3.17; 95% CI: 1.09-
9.34; p < 0.03).
DISCUSSION
In our study the incidence rate of AO was 7 cases per 
1000 admissions, higher than that reported in literature. 
This may be explained because the Hospital Garrahan is 
a referral center, where neonates are referred for high risk 
and surgical management. The frequency of AO did not 
change along the 16 years of the study. Thus, it appears 
that neonatal AO continues to be an uncommon prob-
lem.
In the neonate, AO is usually due to a blood-borne 
spread of infection to bones or joints. Risk factors are 
therefore closely related to the risk of bacteremia.
Complications of pregnancy, labor, or delivery pre-
cede the occurrence of neonatal AO in one third to one 
half of patients.5 Associated risk factors included prema-
turity, low birth weight, asphyxia, bacteremia, and the 
presence of intravenous or umbilical catheter.6,7 In a re-
view of more than 300 cases of neonatal AO, male infants 
predominate over females (1,6:1), and premature infants 
acquire osteoarthritis with a relatively greater frequency 
than do term infants.8 In our study, risk factors for infec-
tion were present in 53 patients (69%); mostly related to 
nosocomial infections, such as high-risk pregnancies and 
use of central catheters.
Clinical presentations in the neonate differ from older 
children. This can be explained partly by the neonate’s 
blood supply to the bone. The metaphyseal vessels com-
municate with the epiphyseal vessels in the cartilaginous 
precursor of the ossific nucleus. This facilitates a rapid 
spread of the infection from the metaphysis to the epiph-
ysis, which is often destroyed, offering a route of infection 
into the joint. This explains why in the neonate arthritis 
and osteomyelitis often coexist.9 
The diagnosis of AO in neonates is often delayed be-
cause of nonspecific symptoms, and may be discovered 
accidentally in the course of routine radiographic exami-
nations, or it may not be apparent until the formation of 
a local subcutaneous abscess. Local signs may be mild and 
systemic symptoms may be absent, being irritability the 
unique sign.10,11,12 Clinical presentation may be divided 
into two groups: The first is the “benign or mild form”, 
Table 4. Risk factor and microbiological isolation
Organisms Commu- Noso- CVC Mecha- NEC Cort
n = 66 nity comial  nical
 Acquired Infection  ventilation
S. aureus 15 22 12 6 2 2
(n = 37)  (40%) (60%) (33%) (16%) (5%) (5%)
S. epidermidis 0 2 2 2 0 0
(n = 2)  (100%) (100%) (100%)
Gram - 1 15 6 2 0 0
negative) (6%) (94%) (38%) (13%)
bacilli (n: 16)
S. agalactiae 10 0 0 0 0 0
 (n = 10) (100%)
H. influenzae  1 0 0 0 0 0
n 27 39 20 10 2 2
CVC, Cenral vascular catheterization; NEC, necrotizing ente-
rocolitis; Cort, steroid.
Considering nosocomial acquired infection (49), all of 
them presented with local symptomatology and only 23 
patients (47%) with systemic manifestation such as fever 
and sepsis. The median time to the diagnosis was two days 
(r: 1-15d). 
Bone radiological changes were observed in 29 patients 
(38%) at the initial evaluation; osteolytic lesions were the 
most frequently observed radiographic images (Figure 1).
Berberian, Firpo, Soto et al.
Figure 1: Severe sequelae of neonatal bone-joint infection in 
the right hip.
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were preceding bacteremia is of low grade or transient, 
with a little or no evidence of infection other than local 
swelling or disability, and symptoms may last for several 
weeks. The other is the “severe form”, where prolonged 
or intense bacteremia is frequent and systemic manifesta-
tions of sepsis predominate with an acute presentation 
with common multiple joint involvement.13 
In our patients, as in other reports, the “benign form” 
was more frequent. Pain and limitation of motion were 
the most common clinical presentations (90% and 96% 
respectively). Other local signs such as swelling were 
present in 58 patients (75%) and erythema in 35 (45%). 
Fever was present in only 50% of the patients. 
A report of 485 newborns with AO the lower extremi-
ties was involved in more than 70%, similarly to most 
reports.13,14 Eighty percent of our patients had lower 
extremities involvement (knee, hip, and ankle), the hip 
being the most frequent site of infection in 47 patients 
(60%) followed by the knee in 23 patients (30%). In the 
upper extremities, the shoulder was the most frequently 
involved site. 
Multiple bone involvement is more frequent in the 
newborn, and has been reported in 20% to 50% of ne-
onates with OA foci.15 In our study there was multifocal 
involvement in 18% of the cases. 
Plain film radiographs are still the most useful means 
for establishing the diagnosis of neonatal OA. Neonates 
show definite signs of bone destruction by the 7th to 10th 
day of illness.13 The use of ultrasonography has been of 
increasing interest for bone and joint infections. Experi-
ence with CT an MRI is limited, as they are used in special 
situations after the other conventional methods. In our 
experience, abnormal radiographs were found in 29 pa-
tients (37%) at the initial evaluation.
The white blood cell count (WBC) is of little value in 
diagnosing neonatal AO. In more than 150 cases, in which 
these values were recorded, the median WBC count was 
17.000 (r: 4.000-75.000); PMN leucocytes represented 
about 60% of WBC. The sedimentation rate is often el-
evated, and is helpful for diagnosis and follow-up when 
elevated, but cannot be used to rule out OA infection.17 It 
reacts slowly to resolution of inflammation; frequently, 
it still rises as clinical improvement occurs. Even when 
recovery is uneventful, normal rates are not reached un-
til three weeks have elapsed. Alternatively, the C-reactive 
protein (CRP) is a rapid indicator of inflammation and 
tissue necrosis and may be useful as an acute phase re-
actant with more sensitivity in the follow-up. High se-
rial CRP concentration is related with sequelae-prone 
patients.17-18
In our series, the median WBC count was 15.900/
mm3 with neutrophil predominance (70%). ESR was 
elevated initially in 94% of the patients. C-reactive pro-
tein was not evaluated because it was not performed on 
a routine basis. 
Clinical or radiological evidence of joint-space infec-
tion requires confirmation through needle aspiration of 
an inflammatory area, to establish a rapid means of di-
agnosis, in addition to the usual sepsis screening studies. 
In our experience, cultures were positive in 65 patients 
(84%), with blood and joint as the most frequent sites of 
isolation. 
Because most cases arise as a consequence of an early 
bacteremia, the organisms responsible for AO reflected 
the etiology of neonatal sepsis. Gram-positive cocci are 
the most frequently cultured microorganisms represent-
ing more than 85% of isolations, being Staphyloccocus 
aureus the most common. Streptococcus agalactiae have 
become increasingly prevalent, as a late-onset illness dur-
ing the third and forth week of life, usually with a mild 
presentation. AO caused by Gram-negative enteric bacilli 
is relatively uncommon despite the frequency of neonatal 
bacteremia.19 In Stockholm, during 1969 to1979, E. coli 
and Klebsiella-Enterobacter were responsible for about 
30% of neonatal septicemia, but only 5% of bone infec-
tions.5 In contrast, S. aureus, although also causing about 
30% of neonatal bacteremia, was responsible for 75% of 
osteomyelitis. 
In our experience, Gram-positive cocci represented 
75% of all isolations. The predominant causative organ-
ism was Staphylococcus aureus in 37 patients (57%). Group 
B Streptococcus was cultured from 10 patients (15%), en-
teric gram-negative bacilli from 16 (24%), Staphylococcus 
epidermidis from two, and Haemophilus influenzae type b 
from one patient.
Emergence of new pathogens like community-
acquired methicillin-resistant Staphylococcus aureus 
must be considered in newborns with bone and joint 
infection for empirical treatment.20 Successful treat-
ment of osteoarthritis depends on prompt clinical di-
agnosis and identification of the infectious agent. No 
controlled studies of type and duration of therapy of 
these infections exist. General recommendations for 
antibiotic treatment consider that it should be given 
by parenteral route initially and continued during 4 to 
6 weeks. Peltola et al. propose shorter course of treat-
ment in pediatric patients > 3 months old, but only 
few reports is written in newborn patients.21,22 Compli-
cations encountered during prolonged parenteral an-
tibiotic treatment in children with acute OA infection 
are related, such as antimicrobial drug reactions and 
catheter related infections.23 Sequential parenteral-oral 
therapy may be used with close follow-up. Nelson et al. 
showed that a shorter duration of parenteral therapy 
followed by an oral therapy based on patient’s clini-
cal response was not associated with any recurrence 
Osteoarthritis in the neonate: risk factors and outcome
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of infection.24 Longer IV treatments may be needed in 
those high-risk sequelae-prone patients, depending on 
localization and microbiology.25 
In our series, all patients received antibiotic treat-
ment, and 75% (58) also needed open surgical drainage, 
especially for hip and shoulder localization. 
Treatment duration had a median time of 40 days, 
with a mean of 21 days of intravenous treatment. Most 
patients (91%) received sequential parenteral- oral treat-
ment. The minority (9%) received IV antibiotics alone. 
The mortality related to AO is low and is associated 
with the presence of sepsis. In our experience only one 
patient died, and it was because of sepsis.
A number of studies document a poor outcome even 
with modern treatment facilities. Neonatal AO can lead 
to permanent joint disabilities or disturbances in skeletal 
growth secondary to damage to the cartilaginous growth 
plate. These include arthritis, decreased range of motion, 
limb-length discrepancy, and gait abnormalities. The re-
ported incidence of permanent sequelae varies from 6% 
to 50%.3,6 Osteoarticular disabilities was found in 38% of 
our patients.
Multiple risk factors are associated with sequelae-
prone cases: delay in diagnosis or surgical drainage, in-
volvement of hip or shoulder, short duration of antimi-
crobial therapy, high serial serum CRP concentrations or 
high ESR, and slow clinical response to treatment.26 Other 
studies reported that the presence of concomitant osteo-
myelitis and methicilin-resistant Staphylococcus aureus 
infection was associated with a significantly increased 
risk of sequelae.27,28 
We analyzed risk factors of sequelae in the 77 patients. 
Adverse outcome was associated with hip involvement, 
culture positivity, and Stapyloccocus aureus isolation. The 
other evaluated factors were non-significant for adverse 
outcome.
 
CONCLUSIONS
Bone and joint infections are severe complications in the 
newborn period. There are risk factors associated with 
unfavorable outcomes. In our experience, hip involve-
ment and microbiological isolation were risk factors for 
an unfavorable long-term outcome. 
Considering the low incidence, paucity of symp-
toms, and associated morbidity, a high degree of sus-
picion is needed to diagnose AO in the newborn. Ap-
propriate management with antibiotics and surgical 
drainage in selected cases are important to prevent 
long term morbidity.
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